Functional Approaches in Promoting Vascularization and Angiogenesis in Bone Critical-Sized Defects via Delivery of Cells, Growth Factors, Drugs, and Particles
Source abstract
Abstract
Critical-sized bone defects, or CSDs, are defined as bone defects that cannot be regenerated by themselves and require surgical intervention via employing specific biomaterials and a certain regenerative strategy. Although a variety of approaches can be used to treat CSDs, poor angiogenesis and vascularization remain an obstacle in these methods. The complex biological healing of bone defects depends directly on the function of blood flow to provide sufficient oxygen and nutrients and the removal of waste products from the defect site. The absence of vascularization can lead to non-union and delayed-union defect development. To overcome this challenge, angiogenic agents can be delivered to the site of injury to stimulate vessel formation. This review begins by introducing the treatment methods for CSDs. The importance of vascularization in CSDs is subsequently highlighted. Delivering angiogenesis agents, including relevant growth factors, cells, drugs, particles, cell secretion substances, their combination, and co-delivery to CSDs are fully explored. Moreover, the effects of such agents on new bone formation, followed by vessel formation in defect areas, are evaluated.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Angiogenesis and VEGF in Cancer · Hemostasis and retained surgical items
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Biomedical Engineering, University of Sydney, Sydney, NSW 2006, Australia
School of Dentistry, Marquette University, Milwaukee, WI 53207, USA
Biomaterial Group, Faculty of Biomedical Engineering, Amirkabir University of Technology, Tehran 15916-34311, Iran
Funding
National Institute of Dental & Craniofacial Research of the National Institutes of Health
References (100+)
Show source-provided references
1. The critical size defect as an experimental model for craniomandibulofacial nonunions10.1097/00003086-198604000-00036 ↗
2. The biology of fracture healing10.1016/j.injury.2011.03.031 ↗
3. Bilateral double site (calvarial and mandibular) critical-size bone defect model in rabbits for evaluation of a craniofacial tissue engineering constructs10.1016/j.mtbio.2022.100267 ↗
4. The efficacy of cylindrical titanium mesh cage for the reconstruction of a critical-size canine segmental femoral diaphyseal defect10.1002/jor.20154 ↗
5. Bone defect animal models for testing efficacy of bone substitute biomaterials
6. The management of fractures with bone loss10.1302/0301-620X.87B2.15874 ↗
7. Exosomes secreted by human-induced pluripotent stem cell-derived mesenchymal stem cells repair critical-sized bone defects through enhanced angiogenesis and osteogenesis in osteoporotic rats10.7150/ijbs.14809 ↗
8. New use for old drug: Local delivery of puerarin facilitates critical-size defect repair in rats by promoting angiogenesis and osteogenesis
9. Repair of critical-sized mandible defects in aged rat using hypoxia preconditioned BMSCs with up-regulation of Hif-1α10.7150/ijbs.24158 ↗
10. Enhanced angiogenesis and osteogenesis in critical bone defects by the controlled release of BMP-2 and VEGF: Implantation of electron beam melting-fabricated porous Ti6Al4V scaffolds incorporating growth factor-doped fibrin glue10.1088/1748-6041/10/3/035013 ↗
11. The repair of critical-size defects with porous hydroxyapatite/polyamide nanocomposite: An experimental study in rabbit mandibles10.1016/j.ijom.2010.01.013 ↗
12. Microarchitecture of rabbit mandibular defects grafted with intramembranous or endochondral bone shown by micro-computed tomography10.1016/S0266-4356(03)00169-4 ↗
13. Prefabrication technique by preserving a muscular pedicle from masseter muscle as an in vivo bioreactor for reconstruction of mandibular critical-sized bone defects in canine models10.1002/jbm.b.35028 ↗
14. Localized, direct plasmid gene delivery in vivo: Prolonged therapy results in reproducible tissue regeneration10.1038/10473 ↗
15. Treatment options for critical size defects-Comparison of different materials in a calvaria split model in sheep10.1016/j.bioadv.2022.212788 ↗
16. GAROT, C., Schoffit, S., Monfoulet, C., Machillot, P., DEROY, C., ROQUES, S., VIAL, J., Vollaire, J., Renard, M., and Ghanem, H. (2022). 3D-printed polymeric scaffolds with optimized architecture to repair a sheep metatarsal critical-size bone defect. bioRxiv.10.1101/2022.12.14.520447 ↗
17. Regenerative approaches for the treatment of large bone defects10.1089/ten.teb.2020.0281 ↗
18. Treatment of critical-sized bone defects: Clinical and tissue engineering perspectives10.1007/s00590-017-2063-0 ↗
19. Pre-vascularization of bone tissue-engineered constructs10.1186/scrt307 ↗
20. Chau, L.T., Frith, J.E., Mills, R.J., Menzies, D.J., Titmarsh, D.M., Cooper–White, J.J., and Zhou, Y. (2021). Microfluidic Devices for Biomedical Applications, Elsevier.
21. Folkman, J. (1984). Biology of Endothelial Cells, Springer.
22. Vascularization strategies in bone tissue engineering10.3390/cells10071749 ↗
23. Bone grafts in dentistry10.4103/0975-7406.113312 ↗
24. Clinical and histologic observations of sites implanted with intraoral autologous bone grafts or allografts. 15 human case reports10.1902/jop.1996.67.10.1025 ↗
25. Clinical applications of bone graft substitutes10.1016/S0030-5898(05)70158-9 ↗
26. Transmission of the hepatitis-C virus by tissue transplantation10.2106/00004623-199502000-00007 ↗
27. The effect of residual calcium in decalcified freeze-dried bone allograft in a critical-sized defect in the Rattus norvegicus calvarium10.1563/780.1 ↗
28. Autogenous and xenogeneic bone grafts for the bone regeneration. A literature review
29. Bone repair of critical size defects treated with autogenic, allogenic, or xenogenic bone grafts alone or in combination with rhBMP-210.1111/clr.12622 ↗
30. Synthetic and Bone tissue engineering graft substitutes: What is the future?10.1016/j.injury.2020.07.040 ↗
31. Tissue engineered bone grafts: Biological requirements, tissue culture and clinical relevance10.2174/157488808786733962 ↗
32. 3D printing of tissue engineering scaffolds: A focus on vascular regeneration10.1007/s42242-020-00109-0 ↗
33. Kalsi, S., Singh, J., Sehgal, S., and Sharma, N. (2021). Biomaterials for tissue engineered bone Scaffolds: A review. Mater. Today Proc.10.1016/j.matpr.2021.04.273 ↗
34. Performance of different osteosynthesis materials in microvascular fibula free flap reconstruction10.1016/j.bjoms.2021.10.013 ↗
35. Anaesthetic implications of free-flap microvascular surgery for head and neck malignancies–A relook10.4103/joacp.JOACP_22_20 ↗
36. Induced membrane technique for the treatment of bone defects due to post-traumatic osteomyelitis10.1302/2046-3758.53.2000487 ↗
37. Induced membrane technique for reconstruction to manage bone loss10.5435/JAAOS-20-03-142 ↗
38. Alveolar distraction osteogenesis versus autogenous onlay bone graft for vertical augmentation of severely atrophied alveolar ridges after 12 years of long-term follow-up10.1016/j.oooo.2013.06.037 ↗
39. Distraction osteogenesis: Mandible and maxilla10.1055/s-0041-1727248 ↗
40. Mandibular distraction osteogenesis: A historic perspective and future directions10.1016/S0889-5406(99)70266-0 ↗
41. The role of vasculature in bone development, regeneration and proper systemic functioning10.1007/s10456-017-9541-1 ↗
42. A technique for quantitative three-dimensional analysis of microvascular structure10.1006/mvre.2002.2395 ↗
43. Angiogenesis in health and disease10.1038/nm0603-653 ↗
44. Tayebi, L., Masaeli, R., and Zandsalimi, K. (2021). 3D Printing in Oral & Maxillofacial Surgery, Springer.10.1007/978-3-030-77787-6 ↗
45. Mechanisms of angiogenesis and arteriogenesis10.1038/74651 ↗
46. Relationships between endothelial cells, pericytes, and osteoblasts during bone formation in the sheep femur following implantation of tricalciumphosphate-ceramic10.1002/ar.1092420304 ↗
47. Does adult fracture repair recapitulate embryonic skeletal formation?10.1016/S0925-4773(99)00142-2 ↗
48. The co-culture of ASCs and EPCs promotes vascularized bone regeneration in critical-sized bone defects of cranial bone in rats10.1186/s13287-020-01858-6 ↗
49. Vascularization strategies in the prevention of nonunion formation10.1089/ten.teb.2020.0111 ↗
50. Concepts of fracture union, delayed union, and nonunion
51. A biomaterial with a channel-like pore architecture induces endochondral healing of bone defects10.1038/s41467-018-06504-7 ↗
52. Construction of nanofibrous scaffolds with interconnected perfusable microchannel networks for engineering of vascularized bone tissue10.1016/j.bioactmat.2021.02.033 ↗
53. Strategies to Promote Vascularization in 3D Printed Tissue Scaffolds: Trends and Challenges10.1021/acs.biomac.2c00423 ↗
54. 3D printed hydrogel scaffolds with macro pores and interconnected microchannel networks for tissue engineering vascularization10.1016/j.cej.2021.132926 ↗
55. Vascularization and bone regeneration in a critical sized defect using 2-N, 6-O-sulfated chitosan nanoparticles incorporating BMP-210.1016/j.biomaterials.2013.10.005 ↗
56. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model10.1016/j.bone.2008.06.019 ↗
57. He, X., Dziak, R., Yuan, X., Mao, K., Genco, R., Swihart, M., Sarkar, D., Li, C., Wang, C., and Lu, L. (2013). BMP2 genetically engineered MSCs and EPCs promote vascularized bone regeneration in rat critical-sized calvarial bone defects. PLoS ONE, 8.10.1371/journal.pone.0060473 ↗
58. Bone formation and neovascularization mediated by mesenchymal stem cells and endothelial cells in critical-sized calvarial defects10.1089/ten.tea.2010.0338 ↗
59. Understanding angiogenesis and the role of angiogenic growth factors in the vascularisation of engineered tissues10.1007/s11033-020-06108-9 ↗
60. VEGF-activated angiogenesis during bone regeneration10.1016/j.joms.2005.05.303 ↗
61. Vascular-specific growth factors and blood vessel formation10.1038/35025215 ↗
62. Angiogenesis in bone regeneration10.1016/j.injury.2011.03.035 ↗
63. Transforming growth factor-β signal transduction in angiogenesis and vascular disorders10.1378/chest.128.6_suppl.585S ↗
64. Vascular endothelial growth factor (VEGF) and its role in non-endothelial cells: Autocrine signalling by VEGF10.1007/978-1-4419-9148-5_13 ↗
65. Integrin-specific hydrogels functionalized with VEGF for vascularization and bone regeneration of critical-size bone defects10.1002/jbm.a.35626 ↗
66. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects10.1359/JBMR.050701 ↗
67. Angiogenesis and bone regeneration of porous nano-hydroxyapatite/coralline blocks coated with rhVEGF165 in critical-size alveolar bone defects in vivo
68. The role of the TGF-β superfamily in myocardial infarction10.3389/fcvm.2019.00140 ↗
69. Role of transforming growth factor-beta in bone remodeling10.1097/00003086-199001000-00036 ↗
70. Comparative study assessing effects of sonic hedgehog and VEGF in a human co-culture model for bone vascularisation strategies10.22203/eCM.v021a12 ↗
71. Regulation of fracture repair by growth factors10.3181/00379727-200-43410A ↗
72. Guerrero, P.A., and McCarty, J.H. (2017). Physiologic and Pathologic Angiogenesis-Signaling Mechanisms and Targeted Therapy, InTechOpen.
73. Growth differentiation factor 15 promotes blood vessel growth by stimulating cell cycle progression in repair of critical-sized calvarial defect10.1038/s41598-017-09210-4 ↗
74. Bevacizumab10.1634/theoncologist.2009-0317 ↗
75. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model10.1097/00003086-199404000-00046 ↗
76. Growth factors in bone10.1007/s002640050290 ↗
77. Acceleration of bone regeneration in critical-size defect using BMP-9-loaded nHA/ColI/MWCNTs scaffolds seeded with bone marrow mesenchymal stem cells
78. Fibroblast growth factor. Chemical structure and biologic function10.1097/00003086-199008000-00038 ↗
79. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels10.1016/0168-3659(94)00035-2 ↗
80. Basic fibroblast growth factor up-regulates the expression of vascular endothelial growth factor during healing of allogeneic bone graft10.1016/j.archoralbio.2004.05.012 ↗
81. Dual release of growth factor from nanocomposite fibrous scaffold promotes vascularisation and bone regeneration in rat critical sized calvarial defect10.1016/j.actbio.2018.07.050 ↗
82. Polymeric system for dual growth factor delivery10.1038/nbt1101-1029 ↗
83. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects10.1359/jbmr.060120 ↗
84. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone10.1038/nature13145 ↗
85. Motivating role of type H vessels in bone regeneration10.1111/cpr.12874 ↗
86. Unique bone marrow blood vessels couple angiogenesis and osteogenesis in bone homeostasis and diseases10.1111/nyas.14348 ↗
87. Endothelial progenitor cells and mesenchymal stem cells seeded onto β-TCP granules enhance early vascularization and bone healing in a critical-sized bone defect in rats10.1089/ten.tea.2009.0715 ↗
88. Endothelial progenitor cells from peripheral blood support bone regeneration by provoking an angiogenic response10.1016/j.mvr.2014.12.001 ↗
89. Isolation of putative progenitor endothelial cells for angiogenesis10.1126/science.275.5302.964 ↗
90. Exosomes secreted by endothelial progenitor cells accelerate bone regeneration during distraction osteogenesis by stimulating angiogenesis10.1186/s13287-018-1115-7 ↗
91. Angiogenic and osteogenic synergy of human mesenchymal stem cells and human umbilical vein endothelial cells cocultured on a nanomatrix10.1038/s41598-018-34033-2 ↗
92. Extracellular vesicles derived from human adipose-derived stem cells promote the exogenous angiogenesis of fat grafts via the let-7/AGO1/VEGF signalling pathway10.1038/s41598-020-62140-6 ↗
93. The crosstalk between osteodifferentiating stem cells and endothelial cells promotes angiogenesis and bone formation10.3389/fphys.2019.01291 ↗
94. Cocultivation of mesenchymal stem cells and endothelial progenitor cells reveals antiapoptotic and proangiogenic effects10.1159/000478654 ↗
95. Generating specificity and diversity in the transcriptional response to hypoxia10.1038/nrg2665 ↗
96. Molecular and biological properties of vascular endothelial growth factor10.1007/s001099900019 ↗
97. Cell type–specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 110.1161/01.RES.0000102937.50486.1B ↗
98. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-110.1038/nm1075 ↗
99. Synergistic effects of dimethyloxalylglycine and butyrate incorporated into α-calcium sulfate on bone regeneration10.1016/j.biomaterials.2014.10.054 ↗
100. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation10.1073/pnas.1410609111 ↗